All lobbying filings
The KPM Group DC LLC
The KPM Group DC LLC filed a Q4 report for Soleno Therapeutics, Inc. on January 14, 2026, reporting $50,000 in lobbying income.
Lobbying for Soleno Therapeutics, Inc. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 14, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
California
Government bodies contacted
2
Lobbying activity
1
H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act S.527, Prescription Pricing for the People Act H.R.2450, Prescription Drug Transparency and Affordability Act S.882, Patients Before Middlemen Act S.526, Pharmacy Benefit Manager Transparency Act